STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
STRATEC Biomedical AG
21.05.2012 16:09
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
With letter dated May 16, 2012, Allianz Global Investors
Kapitalanlagegesellschaft mbH, Frankfurt/Main, Germany, has notified us
pursuant to section 21 (1) sentence 1 of the German Securities Trading Act
(WpHG) as follows:
'We hereby give notice pursuant to section 21 (1) sentence 1 of the German
Securities Trading Act (WpHG) that our voting rights in STRATEC Biomedical
AG, Gewerbestr. 37, 75217 Birkenfeld, exceeded the threshold of 3% on May
14, 2012 and on that day amount to 3.02% of all voting rights of the
Company (this reflects 352,872 of all 11,674,895 voting rights).
With respect to our voting rights, 0.19% of all voting rights (this
reflects 22,762 of all 11,674,895 voting rights) are attributed to us
pursuant to section 22 (1) sentence 1 number 6 of the German Securities
Trading Act (WpHG).'
21.05.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com
End of Announcement DGAP News-Service
back